Early research (Phase 1)Ended earlyNCT01288430What this trial is testingDS-2248 in Participants With Advanced Solid TumorsWho this might be right forSolid TumorsNon-small Cell Lung Carcinoma Daiichi Sankyo 60
Testing effectiveness (Phase 2)Ended earlyNCT01113801What this trial is testingA Study in Participants With Diabetic Kidney DiseaseWho this might be right forDiabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis Eli Lilly and Company 417
Testing effectiveness (Phase 2)Study completedNCT01756456What this trial is testingEvaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.Who this might be right forNeurotrophic KeratitisKeratitisCorneal Ulcer Dompé Farmaceutici S.p.A 174
Large-scale testing (Phase 3)Ended earlyNCT05493501What this trial is testingAumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung CancerWho this might be right forNSCLC EQRx International, Inc. 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07665853What this trial is testingOptimizing the Use of Aspirin for the Prevention of PreeclampsiaWho this might be right forPreeclampsia Hospital Universitari Vall d'Hebron Research Institute 15,160
Not applicableEnded earlyNCT01814345What this trial is testingHer 2 Testing in Indian Patients With Gastric CancerWho this might be right forGastric Cancer Tata Memorial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00233519What this trial is testingEffects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)Who this might be right forMyotonic Dystrophy University of Rochester 17
Not applicableStudy completedNCT03635931What this trial is testingSurgical Treatment With Concentrated Growth Factor for Multiple Papillary LossesWho this might be right forPapilla, Dentinal; Calcification Gazi University 40
Early research (Phase 1)Study completedNCT03235570What this trial is testingA Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)Who this might be right forSolid Tumors Incyte Corporation 44
Testing effectiveness (Phase 2)Study completedNCT00392769What this trial is testingCetuximab in Patients With Progressive or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)UnknownNCT05968118What this trial is testingAngiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD PatientsWho this might be right forPeripheral Artery Disease Beijing Northland Biotech. Co., Ltd. 36
Large-scale testing (Phase 3)Looking for participantsNCT07003074What this trial is testingA Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 642
Testing effectiveness (Phase 2)Study completedNCT01441427What this trial is testingEnteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled TrialWho this might be right forFeeding IntoleranceNecrotizing Enterocolitis Ain Shams University 93
Testing effectiveness (Phase 2)Study completedNCT00632723What this trial is testingIRESSA™ (Gefitinib) in Breast Cancer PatientsWho this might be right forBreast Cancer AstraZeneca 54
Testing effectiveness (Phase 2)Ended earlyNCT01539590What this trial is testingStudy to Evaluate the Safety and Activity of BB3 to Treat Heart AttackWho this might be right forMyocardial Infarction Angion Biomedica Corp 5
Testing effectiveness (Phase 2)Looking for participantsNCT07485452What this trial is testingBoosting Osimertinib Blood Brain Barrier PenetrationWho this might be right forNon-Small Cell Lung Cancer Maastricht University Medical Center 7
Testing effectiveness (Phase 2)UnknownNCT02116348What this trial is testingCerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral PalsyWho this might be right forCerebral Palsy ChildrenChildren With Traumatic Brain InjuryMental Handicap+1 more Ain Shams University 100
Large-scale testing (Phase 3)Study completedNCT02145468What this trial is testingClinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)Who this might be right forAcute Coronary Syndrome GlaxoSmithKline 3,503
Testing effectiveness (Phase 2)UnknownNCT03797391What this trial is testingA Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid TumorsWho this might be right forNeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT02871791What this trial is testingPalbociclib With Everolimus + Exemestane In BCWho this might be right forHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastHormone Receptor (HR)-Positive Breast Cancer Dana-Farber Cancer Institute 41